विवरण

According to NIH, autoimmune disorders are conditions in which the body’s immune system mistakenly attacks and destroys healthy tissues of the body by perceiving them as foreign bodies. The majority of autoimmune disorders cause inflammation of affected parts of the body. The most commonly occurring autoimmune disorder include psoriasis, systemic lupus erythematosus, and rheumatoid arthritis, among others. The global autoimmune disorder drugs market in terms of revenue is set to grow by US$ 40 के दौरान अरब 2021-2027, growing at a compound annual growth rate (सीएजीआर) का 9.8% पूर्वानुमान अवधि के दौरान, डेटा और एनालिटिक्स कंपनी स्ट्रैटेजीहेलिक्स के अनुसार. Growth in the geriatric population, increasing prevalence of autoimmune disorders, the rise in technological advancements for the diagnosis of autoimmune diseases are expected to boost the market growth in the coming years.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2017-2020 और पूर्वानुमान करें 2027 covering key market aspects like sales value for autoimmune disorder drugs. The global autoimmune disorder drugs market is segmented on the basis of type, indication, region. प्रकार से, it is categorized into nonsteroidal anti-inflammatory drugs (NSAIDs), and Immunosuppressant drugs. The NSAIDs segment held the largest market share in 2020. By indication, the autoimmune disorder drugs market is divided into rheumatoid arthritis, systemic lupus erythematosus, psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, प्रकार 1 diabetes, और दूसरे. The rheumatoid arthritis segment accounted for the largest market share in 2020. Based on region, the autoimmune disorder drugs market is divided into North America, एशिया प्रशांत, यूरोप, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb (BMS), Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Roche Holding AG, Vertex Pharmaceuticals Inc..

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the autoimmune disorder drugs market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

प्रकार: nonsteroidal anti-inflammatory drugs (NSAIDs), and Immunosuppressant drugs
Indication: rheumatoid arthritis, systemic lupus erythematosus, psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, प्रकार 1 diabetes, और दूसरे
क्षेत्र: उत्तरी अमेरिका, एशिया प्रशांत, यूरोप, and Rest of the World (ROW)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2017 को 2027

हितधारकों के लिए मुख्य लाभ

Get a comprehensive picture of the global autoimmune disorder drugs market
विकास क्षेत्रों और निवेश के रुझानों को इंगित करें
Understand what the future of the global autoimmune disorder drugs market looks like
प्रतिस्पर्धी परिदृश्य और अवसर की खिड़की की पहचान करें

विषयसूची

1. बाज़ार परिभाषा
2. अनुसंधान क्रियाविधि
3. बाजार के आंकड़े & आउटलुक
3.1 बाजार मूल्य
3.2 बाज़ार मूल्य का पूर्वानुमान
4. Autoimmune Disorder Drugs Market by Type
4.1 Nonsteroidal Anti-Inflammatory Drugs (Nsaids)
4.2 Immunosuppressant Drugs
5. Autoimmune Disorder Drugs Market by Indication
5.1 Rheumatoid Arthritis
5.2 Systemic Lupus Erythematosus
5.3 Psoriasis/Psoriatic Arthritis
5.4 Multiple Sclerosis
5.5 Inflammatory Bowel Disease
5.6 प्रकार 1 Diabetes
5.7 अन्य
6. Autoimmune Disorder Drugs Market by Region
6.1 उत्तरी अमेरिका
6.2 एशिया प्रशांत
6.3 यूरोप
6.4 Rest Of The World (Row)
7. कंपनी प्रोफाइल
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 AstraZeneca plc
7.4 Bayer AG
7.5 Bristol Myers Squibb (BMS)
7.6 Johnson & Johnson
7.7 Mylan N.V.
7.8 Novartis AG
7.9 Pfizer Inc.
7.10 Roche Holding AG
7.11 Vertex Pharmaceuticals, इंक.
8. अनुबंध
8.1 स्ट्रेटेजीहेलिक्स के बारे में
8.2 अस्वीकरण